benzyl salicylate has been researched along with glycoprotein e2, hepatitis c virus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartmann, RW; Holzer, M; Klein, CD; Kronenberger, B; Neugebauer, A; Ziegler, S | 1 |
1 other study(ies) available for benzyl salicylate and glycoprotein e2, hepatitis c virus
| Article | Year |
|---|---|
Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interaction.
Topics: Antigens, CD; Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Protein Binding; Salicylates; Structure-Activity Relationship; Tetraspanin 28; Viral Envelope Proteins | 2008 |